IL-17 Signaling Triggers Degradation of the Constitutive NF-κB Inhibitor ABIN-1
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Abstract IL-17 activates NF-κB and induces expression of proinflammatory genes. IL-17 drives disease in autoimmune conditions, and anti–IL-17 Abs have shown impressive success in the clinic. Although produced by lymphocytes, IL-17 predominantly signals in fibroblasts and epithelial cells. IL-17–driven inflammation is kept in check by negative feedback signaling molecules, including the ubiquitin editing enzyme A20, whose gene TNFAIP3 is linked to autoimmune disease susceptibility. The A20 binding inhibitor of NF-κB activation 1 (ABIN-1) is an A20-binding protein encoded by the TNIP1 gene, which is also linked to autoimmune disease susceptibility including psoriasis. Accordingly, we hypothesized that ABIN-1 might play a role in negatively regulating IL-17 signaling activity. Indeed, ABIN-1 enhanced both tonic and IL-17–dependent NF-κB signaling in IL-17–responsive fibroblast cells. Interestingly, the inhibitory activities of ABIN-1 on IL-17 signaling were independent of A20. ABIN-1 is a known NF-κB target gene, and we found that IL-17–induced activation of NF-κB led to enhanced ABIN-1 mRNA expression and promoter activity. Surprisingly, however, the ABIN-1 protein was inducibly degraded following IL-17 signaling in a proteasome-dependent manner. Thus, ABIN-1, acting independently of A20, restricts both baseline and IL-17–induced inflammatory gene expression. We conclude that IL-17–induced signals lead to degradation of ABIN-1, thereby releasing a constitutive cellular brake on NF-κB activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IL-17-NF-κB signaling induces several negative feedback circuits that restrain NF-κB activation, including deubiquitinating enzymes or related factors, including A20 (TNFAIP3), Abin-1 (TNIP1) and USP25”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Cruz et al., 2017
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Secukinumab in plaque psoriasis—results of two phase 3 trials
Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314258 · Cited by 1,997
The non-canonical NF-κB pathway in immunity and inflammation
Sun, S.-C. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.52 · Cited by 1,891 · cited 1×
“Moreover, the gene encoding IkBa is induced in an NF-kB–dependent manner, establishing a negative feedback loop (23).”
BackgroundThe IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585 · cited 2×
“IL-17 blocking therapies have shown considerable efficacy in treating psoriatic patients, and are being evaluated for various other conditions (2).”
BackgroundSelf-citationHerpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A.-M., Painter, S. L., Comeau, M. R., Cohen, J. I., & Spriggs, M. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90070-5 · Cited by 994 · cited 1×
“In the case of IL-17R signaling, the proximal adaptor Act1 is degraded following phosphorylation to temper all downstream signaling events (40), and IkBa is degraded followingphosphorylation tounmask theNF-kBnuclear import signal (41).”
BackgroundAnti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936
Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
Onishi, R. M., & Gaffen, S. L. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03240.x · Cited by 894
Self-citationHueber, W., Patel, D. D., Dryja, T., Wright, A. M., Koroleva, I., Bruin, G., Antoni, C., Draelos, Z., Gold, M. H., the Psoriasis Study Group, et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001107 · Cited by 860
IL-17 Signaling: The Yin and the Yang
Amatya, N., Garg, A. V., & Gaffen, S. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.006 · Cited by 785 · cited 8×
“Notably, many of these inhibitory pathways converge on NF-kB activation (3).”
BackgroundSelf-citationInterleukin 17 is a chief orchestrator of immunity
Veldhoen, M. (2017) · Nature Immunology · doi:10.1038/ni.3742 · Cited by 475 · cited 6×
“For example, ABIN-1 levels decreased after TLR and TNF-a stimulation of bone marrow–derived macrophages with approximately the same kinetics as we observed with IL-17 signaling (35).”
BackgroundInfluentialIL-17–Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
Conti, H. R., & Gaffen, S. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500909 · Cited by 301 · cited 2×
“IL-17 is required to clear extracellular pathogens, particularly fungi such asCandida albicans (1).”
BackgroundSelf-citationHeyninck, K., De Valck, D., Berghe, W. V., Van Criekinge, W., Contreras, R., Fiers, W., Haegeman, G., & Beyaert, R. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.145.7.1471 · Cited by 295 · cited 1×
“Because of its A20-binding capacity, it is frequently assumed that ABIN-1’s functions involve A20 (17, 31, 32).”
BackgroundSelf-citationIdentification of Common Transcriptional Regulatory Elements in Interleukin-17 Target Genes
Shen, F., Hu, Z., Goswami, J., & Gaffen, S. L. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m604597200 · Cited by 294 · cited 4×
“A20 MEFs were transfected with the Lcn2-promoter (18) together with plasmids expressing ABIN-1 or A20.”
BackgroundMethodSelf-citationIL-17/IL-17 receptor system in autoimmune disease: mechanisms and therapeutic potential
Zhu, S., & Qian, Y. (2012) · Clinical Science · doi:10.1042/cs20110496 · Cited by 282
Shen, F., Ruddy, M. J., Plamondon, P., & Gaffen, S. L. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0904490 · Cited by 268 · cited 1×
“Luciferase assays were performed as described (7, 14).”
MethodSelf-citationABIN-1 Binds to NEMO/IKKγ and Co-operates with A20 in Inhibiting NF-κB
Mauro, C., Pacifico, F., Lavorgna, A., Mellone, S., Iannetti, A., Acquaviva, R., Formisano, S., Vito, P., & Leonardi, A. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m601502200 · Cited by 250
Tian, B., Nowak, D. E., Jamaluddin, M., Wang, S., & Brasier, A. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500437200 · Cited by 237 · cited 2×
“NF-kB regulates the gene promoter activity of ABIN-1, inducing its mRNA as a late expression gene compared with the A20 expression after TNF-a stimulation (13, 24).”
BackgroundIL-17 receptor signaling and T helper 17-mediated autoimmune demyelinating disease
Zepp, J., Wu, L., & Li, X. (2011) · Trends in Immunology · doi:10.1016/j.it.2011.02.007 · Cited by 224
Ubiquitin binding mediates the NF-κB inhibitory potential of ABIN proteins
Wagner, S., Carpentier, I., Rogov, V, Kreike, M., Ikeda, F., Löhr, F., Wu, C.-J., Ashwell, J. D., Dötsch, V, Dikic, I., et al. (2008) · Oncogene · doi:10.1038/sj.onc.1211042 · Cited by 223
Self-citationThe activation and regulation of IL-17 receptor mediated signaling
Song, X., & Qian, Y. (2013) · Cytokine · doi:10.1016/j.cyto.2013.03.014 · Cited by 206
ABINs: A20 binding inhibitors of NF-κB and apoptosis signaling
Verstrepen, L., Carpentier, I., Verhelst, K., & Beyaert, R. (2009) · Biochemical Pharmacology · doi:10.1016/j.bcp.2009.02.009 · Cited by 180
Self-citationABIN-1 is a ubiquitin sensor that restricts cell death and sustains embryonic development
Oshima, S., Turer, E. E., Callahan, J. A., Chai, S., Advincula, R., Barrera, J., Shifrin, N., Lee, B., Yen, B., Woo, T., et al. (2009) · Nature · doi:10.1038/nature07575 · Cited by 171 · cited 1×
“ABIN-1 inhibits both basal and IL-17–induced gene expression To delineate the role of ABIN-1 in IL-17–mediated signaling, we assessed IL-17 signaling in immortalized MEFs lacking ABIN-1 (16).”
BackgroundSelf-citationHeyninck, K., & Beyaert, R. (1999) · FEBS Letters · doi:10.1016/s0014-5793(98)01645-7 · Cited by 169 · cited 1×
“Because of its A20-binding capacity, it is frequently assumed that ABIN-1’s functions involve A20 (17, 31, 32).”
BackgroundSelf-citationIL-17 targeted therapies for psoriasis
Chiricozzi, A., & Krueger, J. G. (2013) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.2013.806483 · Cited by 160
Polyubiquitin binding to ABIN1 is required to prevent autoimmunity
Nanda, S. K., Venigalla, R. K. C., Ordureau, A., Patterson-Kane, J. C., Powell, D. W., Toth, R., C. Arthur, J. S., & Cohen, P. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102177 · Cited by 160 · cited 2×
“In vivo, this mutation caused systemic inflammation and autoimmunity (35).”
BackgroundResultGarg, A. V., Amatya, N., Chen, K., Cruz, J. A., Grover, P., Whibley, N., Conti, H. R., Hernandez Mir, G., Sirakova, T., Childs, E. C., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.07.021 · Cited by 145 · cited 1×
“These data thus suggested that ABIN-1 is part of a similar negative feedback loop, analogous to other IL-17 signaling inhibitors such as A20 and MCP1-induced protein 1/Regnase-1 (7, 36).”
ResultSelf-citationThe deubiquitinase A20 mediates feedback inhibition of interleukin-17 receptor signaling
Garg, A. V., Ahmed, M., Vallejo, A. N., Ma, A., & Gaffen, S. L. (2013) · Science Signaling · doi:10.1126/scisignal.2003699 · Cited by 128 · cited 5×
“In prior work, we found that A20 is part of a feedback loop that restricts IL-17–mediated TRAF6 ubiquitination, which is required for NF-kB andMAPK activation; this finding prompted the present analyses of the A20-binding protein ABIN-1 (7).”
BackgroundMethodResultSelf-citationEmerging therapies targeting the ubiquitin proteasome system in cancer
Weathington, N. M., & Mallampalli, R. K. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71602 · Cited by 124 · cited 1×
“Therapeutics targeting the proteasome are used for cancer (43), and might be useful in diseases where ABIN-1 is implicated, i.”
BackgroundStructure–function analysis of the A20‐binding inhibitor of NF‐κB activation, ABIN‐1
Heyninck, K., Kreike, M. M., & Beyaert, R. (2003) · FEBS Letters · doi:10.1016/s0014-5793(03)00041-3 · Cited by 111 · cited 7×
“Abbreviations used in this article: ABIN-1, A20-binding inhibitor of NF-kB activation 1; C/EBP, CCAAT enhancer binding protein; EV, empty vector; IKK, inhibitor of NF-kB kinase; MEF, murine embryonic fibroblast; qPCR, quantitative PCR; siRNA, small interfering RNA; UBAN, ubiquitin binding domain.”
BackgroundSelf-citationABIN1 Protein Cooperates with TAX1BP1 and A20 Proteins to Inhibit Antiviral Signaling
Gao, L., Coope, H. J., Grant, S. M., Ma, A. I., Ley, S. C., & Harhaj, E. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.283762 · Cited by 93 · cited 1×
“Similarly, ABIN-1 cooperates with A20 to inhibit antiviral signaling or TNF-regulated NF-kB signaling (20, 34).”
BackgroundSelf-citationKawasaki, A., Ito, S., Furukawa, H., Hayashi, T., Goto, D., Matsumoto, I., Kusaoi, M., Ohashi, J., Graham, R., Matsuta, K., et al. (2010) · Arthritis Research & Therapy · doi:10.1186/ar3134 · Cited by 89 · cited 1×
“The development of autoimmunity is associated with polymorphisms ingenes that influenceNF-kBactivity, suchasTNFAIP3 (encoding A20), NFKBIA (encoding IkBa), and TNIP1 (encoding ABIN-1) (29, 30).”
BackgroundKeratinocytes contribute intrinsically to psoriasis upon loss of Tnip1 function
Ippagunta, S. K., Gangwar, R., Finkelstein, D., Vogel, P., Pelletier, S., Gingras, S., Redecke, V., & Häcker, H. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1606996113 · Cited by 85 · cited 2×
“Mice in which ABIN-1 is conditionally deleted in keratinocytes develop more severe skin inflammation than control mice after imiquimod-induceddermatitis,which is associatedwith increased expressionof IL-17 target genessuchasCxcl1 andCcl20 (12).”
BackgroundSwindell, W. R., Sarkar, M. K., Liang, Y., Xing, X., & Gudjonsson, J. E. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.04.035 · Cited by 73
Yang, L., Cheng, H., Zuo, X.-B., Sheng, Y., Zhou, F., Tang, X., Tang, H., Gao, J., Zhang, Z., He, S.-M., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2013-101787 · Cited by 65 · cited 1×
“The development of autoimmunity is associated with polymorphisms ingenes that influenceNF-kBactivity, suchasTNFAIP3 (encoding A20), NFKBIA (encoding IkBa), and TNIP1 (encoding ABIN-1) (29, 30).”
BackgroundCutting Edge: ABIN-1 Protects against Psoriasis by Restricting MyD88 Signals in Dendritic Cells
Callahan, J. A., Hammer, G. E., Agelidis, A. M., Duong, B. H., Oshima, S., North, J. P., Advincula, R., Shifrin, N. T., Truong, H.-A., Paw, J. S., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1203335 · Cited by 54
Self-citationShi, P., Zhu, S., Lin, Y., Liu, Y., Liu, Y., Chen, Z., Shi, Y., & Qian, Y. (2011) · Science Signaling · doi:10.1126/scisignal.2001653 · Cited by 50 · cited 1×
“In the case of IL-17R signaling, the proximal adaptor Act1 is degraded following phosphorylation to temper all downstream signaling events (40), and IkBa is degraded followingphosphorylation tounmask theNF-kBnuclear import signal (41).”
BackgroundChen, Y., Yan, H., Song, Z., Chen, F., Wang, H., Niu, J., Shi, X., Zhang, D., Zhang, N., Zhai, Z., et al. (2015) · PLoS ONE · doi:10.1371/journal.pone.0127957 · Cited by 38 · cited 2×
“This might explain the observation that in patients withpsoriasis there is elevatedmRNAbut decreasedprotein levels for ABIN-1 (11).”
BackgroundInhibition of tumor necrosis factor-induced necrotic cell death by the zinc finger protein A20.
Heyninck, K., Denecker, G., VALCK, D. D., Fiers, W., & Beyaert, R. (1999) · PubMed · Cited by 32
Self-citationABIN-1 negatively regulates NF-κB by inhibiting processing of the p105 precursor
Cohen, S., Ciechanover, A. J., Kravtsova‐Ivantsiv, Y., Lapid, D., & Lahav‐Baratz, S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.08.074 · Cited by 32 · cited 1×
“ABIN-1 controls signaling by several reported mechanisms, including (1) inhibiting IKK complex activity by binding to NEMO (IKKg) (20); (2) inhibiting ubiquitination and degradation of p105 to block p50 production in the noncanonical NF-kB pathway (21); and (3) by associating with and thus blocking TNF receptor adapto…”
BackgroundPPARγ and NF-κB regulate the gene promoter activity of their shared repressor, TNIP1
Gurevich, I., Zhang, C., Encarnacao, P. C., Struzynski, C. P., Livings, S. E., & Aneskievich, B. J. (2011) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2011.09.006 · Cited by 25
Self-citationYuan, S., Dong, X., Tao, X., Xu, L., Ruan, J., Peng, J., & Xu, A. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1321187111 · Cited by 21 · cited 1×
“Indeed, ABIN-1 coexpression with A20 was shown to induce destabilization of the IKK complex and inhibition of NF-kB signaling in a lower chordate model organism (33).”
BackgroundLi, X. ‐., Yu, H., & Wu, G. ‐. (2014) · International Journal of Immunogenetics · doi:10.1111/iji.12150 · Cited by 19
TNFAIP3 and TNIP1 polymorphisms confer psoriasis risk in South Indian Tamils
Indhumathi, S., Rajappa, M., Chandrashekar, L., Ananthanarayanan, P., Thappa, D. M., & Negi, V. S. (2015) · British Journal of Biomedical Science · doi:10.1080/09674845.2015.11665748 · Cited by 18
Gurevich, I., Zhang, C., Francis, N., Struzynski, C. P., Livings, S. E., & Aneskievich, B. J. (2012) · Gene · doi:10.1016/j.gene.2012.11.041 · Cited by 12 · cited 1×
“Moreover, IL-17 induction of ABIN-1 occurred at the level of the promoter, as verified in ST2 cells transfectedwith the full-length (6 kb) ABIN-1 proximal promoter (13, 25) (Supplemental Fig.”
BackgroundSelf-citation
Cited by
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“Conversely, IL-17-NF-κB signaling induces several negative feedback circuits that restrain NF-κB activation, including deubiquitinating enzymes or related factors, including A20 (TNFAIP3), Abin-1 (TNIP1) and USP25 (Cruz et al., 2017; Garg et al., 2013; Zhong et al., 2012) (Figure 4).”
BackgroundSelf-citationCornel, A. M., Mimpen, I. L., & Nierkens, S. (2020) · Cancers · doi:10.3390/cancers12071760 · Cited by 464
“Similar to N4BP1, TNIP1 inhibits NFkB by impairing NEMO-mediated translocation of IKK to the receptor site.”
BackgroundInfluentialInterleukin-17A: The Key Cytokine in Neurodegenerative Diseases
Chen, J., Liu, X., & Zhong, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.566922 · Cited by 165
“However, IL-17- NFκB signaling induces several negative feedback circuits to restrain the activation of NF-κB, such as deubiquitination (Garg et al., 2013; Cruz et al., 2017).”
TNIP1 in Autoimmune Diseases: Regulation of Toll-like Receptor Signaling
Shamilov, R., & Aneskievich, B. J. (2018) · Journal of Immunology Research · doi:10.1155/2018/3491269 · Cited by 79
“Interestingly, cultured cells experimentally exposed to IL-17a showed increased rates of TNIP1 protein degradation [113].”
BackgroundSelf-citationTh17 Cells in Helicobacter pylori Infection: a Dichotomy of Help and Harm
Dixon, B. R. E. A., Hossain, R., Patel, R. V., & Algood, H. M. S. (2019) · Infection and Immunity · doi:10.1128/iai.00363-19 · Cited by 58
“Moreover, they also reported that the A20-binding inhibitor of NF- B activation 1 (ABIN-1) negatively regulates the IL-17-induced production of Il6, Lcn2, and a few other NF- B-dependent genes in fibroblasts and stromal cells (97).”
Background
Metadata
- Authors
- Cruz, J. A., Childs, E. E., Amatya, N., Garg, A. V., Beyaert, R., Kane, L. P., Aneskievich, B. J., Ma, A., & Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- Ghent University (BE)
- Department of Immunology, University of Pittsburgh School of Medicine , Pittsburgh, PA 15261
- University of Connecticut (US)
- University of California, San Francisco (US)
- Corresponding author
- Amatya, Nilesh
- ORCID
- Venue
- ImmunoHorizons
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-09-01
- Volume
- 1
- Issue
- 7
- Pages
- 133-141
- ISSN
- 2573-7732 (ISSN-L)
- PMC
- PMC6370333
- OpenAlex
- W2751489398
- Cited by
- 29
- References
- 44
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 6 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 7 · 2019: 2 · 2018: 2
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- ImmunoHorizons (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI103022, R01AI107825)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR048660)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- IL-17 signaling, NF-κB activation, protein degradation, proteasome, A20, TNIP1, negative feedback regulation, fibroblasts, psoriasis, autoimmune disease susceptibility, inflammatory gene expression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.